• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by IBEX Limited (Amendment)

    2/12/24 11:23:53 AM ET
    $IBEX
    EDP Services
    Technology
    Get the next $IBEX alert in real time by email
    SC 13G/A 1 ibexltd13g-a2.htm SC 13G/A Document

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    (Amendment No. 2) *

    IBEX LIMITED
    (Name of Issuer)


    COMMON STOCK
    (Title of Class of Securities)

    G4690M101
    (CUSIP Number)

    DECEMBER 31, 2023
    (Date of Event Which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    X    Rule 13d-1(b)
    ☐    Rule 13d-1(c)
    ☐    Rule 13d-1(d)
    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




    Page 1 of 9 Pages



    image_14.jpgCUSIP No. G4690M101
    1.Names of Reporting Persons
    American Century Capital Portfolios, Inc.
    image_14.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_14.jpg
    3.SEC Use Only

    image_14.jpg
    4.Citizenship or Place of Organization
    Maryland
     
    5.

    Sole Voting Power

    940,000
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    940,000
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    940,000

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    5.24%

    12.

    Type of Reporting Person (See Instructions)

    IV



    Page 2 of 9 Pages



    image_14.jpgCUSIP No. G4690M101
    1.Names of Reporting Persons
    American Century Investment Management, Inc.
    image_14.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_14.jpg
    3.SEC Use Only

    image_14.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power

    1,328,822
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    1,380,395
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    1,380,395

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐
     
           11.

    Percent of Class Represented by Amount in Row (9)

    7.70%

    12.

    Type of Reporting Person (See Instructions)

    IA



    Page 3 of 9 Pages



    image_14.jpgCUSIP No. G4690M101
    1.Names of Reporting Persons
    American Century Companies, Inc.
    image_14.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_14.jpg
    3.SEC Use Only

    image_14.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power

    1,328,822
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    1,380,395
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    1,380,395

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    7.70%

    12.

    Type of Reporting Person (See Instructions)

    HC



    Page 4 of 9 Pages



    image_14.jpgCUSIP No. G4690M101
    1.Names of Reporting Persons
    Stowers Institute for Medical Research
    image_14.jpg
    2.Check the Appropriate Box if a Member of a Group (See Instructions)
    a)☐
    b)☐
    image_14.jpg
    3.SEC Use Only

    image_14.jpg
    4.Citizenship or Place of Organization
    Delaware
     
    5.

    Sole Voting Power

    1,328,822
    Number of Shares
    Beneficially

    6.
     
    Shared Voting Power

     N/A
    Owned by  
    Each
    Reporting
    Person With:

    7.
     
    Sole Dispositive Power

    1,380,395
     
    8.
     
    Shared Dispositive Power

    N/A

    9.

    Aggregate Amount Beneficially Owned by Each Reporting Person

    1,380,395

    10.

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares
    (See Instructions) ☐

    11.

    Percent of Class Represented by Amount in Row (9)

    7.70%

    12.

    Type of Reporting Person (See Instructions)

    HC



    Page 5 of 9 Pages



    Item 1.
    a)Name of Issuer

    Ibex Limited

    b)Address of Issuer’s Principal Executive Offices

    1717 Pennsylvania Avenue NW, Suite 825
    Washington, DC 20006
    Item 2.
    a)Name of Person Filing:
    1)American Century Capital Portfolios, Inc.
    2)American Century Investment Management, Inc.
    3)American Century Companies, Inc.
    4)Stowers Institute for Medical Research

    a)Address of Principal Business Office or, if none, Residence.
    4500 Main Street
    9th Floor
    Kansas City, Missouri 64111

    c)Citizenship.
    1)Maryland
    2)Delaware
    3)Delaware
    4)Delaware

    d)Title of Class of Securities
    Reference is made to the cover page of this filing.

    e)CUSIP Number.
    Reference is made to the cover page of this filing.


    Page 6 of 9 Pages



    Item 3.    If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    1)American Century Capital Portfolios, Inc. is an investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
    2)American Century Investment Management, Inc. is an investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
    3)American Century Companies, Inc. is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    4)Stowers Institute for Medical Research is a parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
    Item 4.     Ownership.
         Reference is made to Items 5-9 and 11 on the cover page of this filing.
    Item 5. Ownership of Five Percent or Less of a Class.
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [ ]
    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. (“ACIM”) serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule.  Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
    See attached Exhibit A.
    Item 8. Identification and Classification of Members of the Group.
    Not applicable.
    Item 9. Notice of Dissolution of Group
    Not applicable






    Page 7 of 9 Pages



    Item 10. Certification
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated this 9th day of February, 2024.

    AMERICAN CENTURY CAPITAL PORTFOLIOS, INC. (“ACCP”)

    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)

    AMERICAN CENTURY COMPANIES, INC. (“ACC”)

    By:     __/s/ John Pak__________________________
        John Pak
        Senior Vice President, ACCP, ACIM and ACC
        

    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC

    By:    __/s/ Richard W. Brown____________________
        Richard W. Brown
        Chairman

    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b).

    EXHIBIT A
    This Exhibit has been prepared to identify each subsidiary of American Century Companies, Inc. (“ACC”), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are the subject of this schedule (the “Subject Securities”).  American Century Investment Management, Inc. (“ACIM”) is a wholly-owned subsidiary of ACC and an investment adviser registered under §203 of the Investment Advisers Act of 1940.
    SCHEDULE 13G – To be included in statements filed pursuant to Rule 13d-1(b) or 13d-2(b) and Rule 13d-1(f) (1) Agreement.


    Page 8 of 9 Pages




    EXHIBIT B
    Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.

    Dated this 9th day of February, 2024.

    AMERICAN CENTURY CAPITAL PORTFOLIOS, INC. (“ACCP”)

    AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. (“ACIM”)

    AMERICAN CENTURY COMPANIES, INC. (“ACC”)

    By:     __/s/ John Pak__________________________
        John Pak
        Senior Vice President, ACCP, ACIM and ACC
        

    STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC

    By:    __/s/ Richard W. Brown____________________
        Richard W. Brown
        Chairman











    Page 9 of 9 Pages

    Get the next $IBEX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IBEX

    DatePrice TargetRatingAnalyst
    5/12/2025$30.00Outperform → Neutral
    Robert W. Baird
    11/10/2023$17.00Overweight → Neutral
    Piper Sandler
    9/14/2023$27.00 → $18.00Outperform → Sector Perform
    RBC Capital Mkts
    7/19/2022$20.00Buy → Neutral
    Citigroup
    2/17/2022$18.00 → $20.00Overweight
    Piper Sandler
    1/13/2022$21.00 → $18.00Overweight
    Piper Sandler
    11/24/2021$23.00 → $21.00Buy
    Citigroup
    11/23/2021$24.00 → $22.00Outperform
    RBC Capital
    More analyst ratings

    $IBEX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ibex Launches the 2025 CX Leadership Awards

      WASHINGTON, May 21, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), the leading global provider of business process outsourcing (BPO) and AI-powered CX solutions, today kicked off the 2025 CX Leadership Awards, which honor the top customer experience (CX) innovators, leaders, and contributors around the world. This year's CX Leadership Award nominees, selected from an ultra-competitive roster of renowned CX experts and visionaries, will be announced over the coming weeks. Winners will be crowned on June 11, 2025 at the ibex CX Leaders Dinner in Las Vegas during Customer Contact Week (CCW). "As the AI-powered CX leader, ibex is pleased to congratulate the 2025 CX Leadership Award nominees fo

      5/21/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • ibex Wave iX Wins Gold Stevie® Award at The 23rd Annual American Business Awards®

      WASHINGTON, May 14, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced that ibex Wave iX has earned the Gold Stevie® Award in the Achievement in Technology Innovation category for The 23rd Annual American Business Awards®. This honor emphasizes the success of ibex's AI-powered Wave iX solution platform in transforming the customer experience for leading brands around the world. "We are proud to be recognized by The Stevie® Awards for The Annual American Business Awards®," said Carl O'Neil, EVP and GM of Wave iX, Augment, and ibex CX. "AI is transforming the cu

      5/14/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance

      Quarterly revenue grew 11% versus prior year quarter - highest growth in ten quartersAdjusted EPS of $0.82 - an increase of 18% to prior year quarterMakes strategic entry into India - launching with leading healthcare clientBoard authorizes a new $15 million share repurchase plan WASHINGTON, May 08, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its third fiscal quarter ended March 31, 2025.  Three months ended March 31, 2025 Nine months ended March 31, 2025($ millions, except per share amounts) 2025   2024  Change  2025   2024  ChangeRe

      5/8/25 4:05:00 PM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • IBEX Ltd. downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded IBEX Ltd. from Outperform to Neutral and set a new price target of $30.00

      5/12/25 8:21:23 AM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Ltd. downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded IBEX Ltd. from Overweight to Neutral and set a new price target of $17.00

      11/10/23 7:31:30 AM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Ltd. downgraded by RBC Capital Mkts with a new price target

      RBC Capital Mkts downgraded IBEX Ltd. from Outperform to Sector Perform and set a new price target of $18.00 from $27.00 previously

      9/14/23 7:19:17 AM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by IBEX Limited

      SC 13D/A - IBEX Ltd (0001720420) (Subject)

      12/6/24 7:28:26 PM ET
      $IBEX
      EDP Services
      Technology
    • Amendment: SEC Form SC 13D/A filed by IBEX Limited

      SC 13D/A - IBEX Ltd (0001720420) (Subject)

      11/22/24 4:17:06 PM ET
      $IBEX
      EDP Services
      Technology
    • Amendment: SEC Form SC 13G/A filed by IBEX Limited

      SC 13G/A - IBEX Ltd (0001720420) (Subject)

      11/8/24 9:16:21 AM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Financials

    Live finance-specific insights

    See more
    • IBEX Reports Record Quarterly Revenue and EPS, Returns to Double-Digit Growth, Raises Fiscal Year Guidance

      Quarterly revenue grew 11% versus prior year quarter - highest growth in ten quartersAdjusted EPS of $0.82 - an increase of 18% to prior year quarterMakes strategic entry into India - launching with leading healthcare clientBoard authorizes a new $15 million share repurchase plan WASHINGTON, May 08, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its third fiscal quarter ended March 31, 2025.  Three months ended March 31, 2025 Nine months ended March 31, 2025($ millions, except per share amounts) 2025   2024  Change  2025   2024  ChangeRe

      5/8/25 4:05:00 PM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Limited to Announce Third Quarter 2025 Financial Results on May 8th, 2025

      WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex") (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced it will report third quarter 2025 financial results after the market close on Thursday, May 8, 2025. Management will host a conference call and webcast to discuss the Company's financial results, recent developments, and business outlook at 4:30 p.m. ET. What:IBEX Limited Announces Third Quarter 2025 Financial ResultsWhen:Thursday, May 8, 2025Time:4:30 p.m. ETLive Call:Register Here for Dial-In and PINWebcast:https://investors.ibex.co/   About ibexibex delivers innovative business pr

      4/24/25 4:30:00 PM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Reports Record Quarterly Revenue and Strong EPS

      Quarterly revenue grew 6.1% versus prior year quarter - highest growth in 9 quartersStrong adjusted EBITDA margin expansion year-over-year - 10 out of the last 11 quarters Adjusted EPS of $0.59 - an increase of 36% to prior year quarterRaises guidance on revenue and lower end of EBITDA rangeRepurchased approximately 3.6 million shares from TRGI during the second quarter of fiscal year 2025, representing 21% of our shares outstanding and eliminating controlled company status WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial resu

      2/6/25 4:05:00 PM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    SEC Filings

    See more
    • SEC Form 10-Q filed by IBEX Limited

      10-Q - IBEX Ltd (0001720420) (Filer)

      5/8/25 4:24:58 PM ET
      $IBEX
      EDP Services
      Technology
    • IBEX Limited filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

      8-K - IBEX Ltd (0001720420) (Filer)

      5/8/25 4:20:07 PM ET
      $IBEX
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by IBEX Limited

      SCHEDULE 13G/A - IBEX Ltd (0001720420) (Subject)

      5/5/25 2:03:05 PM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Sales and CS Officer Dawson Bruce Neil exercised 10,000 shares at a strike of $12.75 and sold $244,800 worth of shares (10,000 units at $24.48) (SEC Form 4)

      4 - IBEX Ltd (0001720420) (Issuer)

      5/16/25 5:15:39 PM ET
      $IBEX
      EDP Services
      Technology
    • Chief Executive Officer Dechant Robert Thomas exercised 49,931 shares at a strike of $12.75 and sold $1,310,189 worth of shares (49,931 units at $26.24) (SEC Form 4)

      4 - IBEX Ltd (0001720420) (Issuer)

      2/27/25 4:54:14 PM ET
      $IBEX
      EDP Services
      Technology
    • Director Khaishgi Mohammedulla sold $322,237 worth of shares (12,600 units at $25.57), decreasing direct ownership by 14% to 77,312 units (SEC Form 4)

      4 - IBEX Ltd (0001720420) (Issuer)

      2/21/25 4:37:48 PM ET
      $IBEX
      EDP Services
      Technology

    $IBEX
    Leadership Updates

    Live Leadership Updates

    See more
    • ibex Names Phil Taylor Country Manager for Jamaica

      KINGSTON, Jamaica, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced the appointment of Phil Taylor as Senior Vice President and Country Manager for Jamaica. In his new role, Phil will report directly to David Wilkerson, Executive Vice President of Global Operations, and will oversee the company's operations and strategic initiatives in Jamaica. Phil joined ibex two years ago as Vice President of Operations and has since become an integral part of the organization. With over 20 years of experience in the contact center industry, Phil has built a re

      2/12/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • ibex Appoints Karen Batungbacal to Board of Directors

      WASHINGTON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- IBEX Limited ("ibex"), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced the appointment of Karen Batungbacal to its Board of Directors. Batungbacal will begin her official duties as a board member on January 20, 2025. "We are excited to welcome Karen to our Board of Directors," said Bob Dechant, Board Member and Chief Executive Officer of ibex Limited. "As we continue to pursue our strategy to redefine customer experience (CX) with AI and further grow in key vertical markets and geographies, Karen is the ideal partner to help guide our growth as we scale efficien

      1/6/25 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology
    • ibex CTO Andreas Wilkens to Join Distinguished Panel on AI Ethics and Business Innovation

      WASHINGTON, Nov. 20, 2024 (GLOBE NEWSWIRE) -- ibex (NASDAQ:IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced that ibex Chief Technology Officer Andreas Wilkens will join industry leaders from SAP, Google, and Microsoft for a high-level panel discussion on ethical AI implementation in business. The panel – AI for Competitive Edge: Balancing Innovation and Ethics for Growth – will be hosted by SAP in Bellevue, Wash. on Thursday, November 21, 2024. The panel, which will be moderated by Monika Sengul-Jones of the University of Washington, will discuss critical themes including Bias and Fairness, Priv

      11/20/24 9:00:00 AM ET
      $IBEX
      EDP Services
      Technology